케어랩스
Financials
Valuation Metrics
케어랩스's Market Cap is ₩383B. At end of 2025 it was ₩571B. Ranked #1876 of 2,405 in KR market (top 78%), #1163 of 1,627 on KOSDAQ (top 71%), #78 of 94 in Health Care Equipment & Services (top 83%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 38.32B KRW | KR#1,876/2,405 Sec#78/94 |
| Revenue | 74.01B KRW | KR#1,588/2,405 Sec#45/94 |
| Net Income | -6.66B KRW | KR—/2,405 Sec—/94 |
| Total Assets | 107.43B KRW | KR#1,724/2,405 Sec#53/94 |
| Net Assets | 74.63B KRW | KR#1,633/2,405 Sec#49/94 |
| Employees | 120 | KR#1,502/2,405 Sec#52/94 |
| Value | ||
| P/B | 0.51x | KR#898/2,405 Sec#12/94 |
| P/S | 0.52x | KR#998/2,405 Sec#11/94 |
| FCF Yield | -39.61% | KR—/2,405 Sec—/94 |
| Profitability | ||
| ROE | -8.93% | KR#1,912/2,405 Sec#65/94 |
| ROA | -6.20% | KR#1,977/2,405 Sec#68/94 |
| Op. Margin | -8.57% | KR#1,948/2,405 Sec#61/94 |
| Revenue Growth | -14.97% | KR#2,025/2,405 Sec#83/94 |
| Earnings Growth | -153.48% | KR#1,204/2,405 Sec#41/94 |
| Financial Health | ||
| Debt Ratio | 43.95% | KR#862/2,405 Sec#47/94 |
| Total Debt | 0 KRW | KR—/2,405 Sec—/94 |
| FCF | -15.18B KRW | KR#1,814/2,405 Sec#68/94 |
| Cash | 39.76B KRW | KR#856/2,405 Sec#19/94 |
| Current Ratio | 1.66x | KR#1,061/2,405 Sec#62/94 |
| Dividend | ||
| Div. Yield | 3.96% | KR#486/2,405 Sec#4/94 |
| Div. Growth | 4.92% | KR#657/2,405 Sec#22/94 |
| Performance | ||
| 1Y Return | -50.34% | KR#1,959/2,405 Sec#71/94 |
| 1M Return | -11.48% | KR#1,294/2,405 Sec#50/94 |
| From 52W High | -54.15% | KR#1,357/2,405 Sec#51/94 |
| 1Y MDD | -62.36% | KR#1,574/2,405 Sec#52/94 |
| Trading | ||
| Volume | 5,506 shares | KR#2,065/2,405 Sec#83/94 |
| Trading Value | 10.9M KRW | KR#2,233/2,405 Sec#89/94 |
| Foreign Own. | 2.71% | KR#1,373/2,405 Sec#47/94 |
| Per Share | ||
| EPS | -343 KRW | KR—/2,405 Sec—/94 |
| BPS | 3,844 KRW | KR#1,709/2,405 Sec#45/94 |
Company Info
CARE LABS, established in 2012 and listed on KOSDAQ in 2018, owns EDB, Goodoc, and Babitalk. The company generates synergy through its marketing and CRM businesses for medical institutions, primarily centered on mobile healthcare and beauty care platforms. As of the end of the half-year, its revenue breakdown is 42.69% from platforms, 38.07% from marketing, and 19.24% from solutions. CARE LABS is expanding its platform business in response to the growth of digital healthcare and increasing public interest in personal health management, and is headquartered in Gangnam-gu, Seoul Metropolitan City.